Bright Angel Therapeutics
Latest round
- Seed
Last raised
- Dec 2019
Total raised
- Undisclosed
Investors
- 2
About Bright Angel Therapeutics
Based in Toronto, Canada, Bright Angel Therapeutics researches and develops novel therapeutics for fungal infections. The novel drugs that target key regulatory proteins involved in the antifungal stress response as it has been shown that an intact fungal stress response is needed for the emergence and maintenance of antifungal drug resistance.
Who invested in Bright Angel Therapeutics
2 investors across 1 round
See all investors in Bright Angel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 3, 2019
Amount
Undisclosed
Investors
Questions about Bright Angel Therapeutics
Who invested in Bright Angel Therapeutics?
Bright Angel Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bright Angel Therapeutics raised?
Bright Angel Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bright Angel Therapeutics last raise money?
Bright Angel Therapeutics's most recent round on record is a Seed, in Dec 2019.
What does Bright Angel Therapeutics do?
Based in Toronto, Canada, Bright Angel Therapeutics researches and develops novel therapeutics for fungal infections.
Where is Bright Angel Therapeutics headquartered?
Bright Angel Therapeutics is headquartered in Toronto, Canada.
Which VCs invest in companies like Bright Angel Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bright Angel Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Bright Angel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.